ACUR OTC
Acura Pharmaceuticals, Inc.
1W: -1.0%
1M: -0.0%
3M: -88.9%
YTD: -80.0%
1Y: -75.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$2M
Revenue
-56.2% YoY
$-1M
Net Income
+27.2% YoY
$-1M
Free Cash Flow
-3.2% YoY
25.0%
Gross Margin
-658.3%
Op. Margin
80.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE30.8%
ROA-67.7%
ROIC-306.4%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA-62.6
Leverage
Debt/Equity1.12
Current Ratio0.72
Interest Cov.-3.4x
Quality Scores
Piotroski F4/9
Altman Z-602.75
Beneish M1.79